The cell membrane repair protein MG53 modulates transcription factor NF-κB signaling to control kidney fibrosis

Haichang Li1, Pu Duann2, Zhongguang Li1

  • 1Department of Surgery, Davis Heart and Lung Research Institute, The Ohio State University, Columbus, Ohio, USA.

Kidney International
|November 10, 2021
PubMed

Insights

The cell membrane repair protein MG53 protects against kidney fibrosis and inflammation. MG53 deficiency exacerbates kidney fibrosis, while enhancing MG53 levels offers therapeutic potential for chronic kidney disease.

Area of Science:

  • Nephrology
  • Cell Biology
  • Biochemistry

Background:

  • Kidney fibrosis is a key factor in the progression of acute kidney injury to chronic kidney disease.
  • MG53, a cell membrane repair protein, has demonstrated protective effects against kidney epithelial cell injury and acute kidney injury.
  • The role of MG53 in kidney fibrosis, particularly in aging and disease models, requires further investigation.

Purpose of the Study:

  • To investigate the role of MG53 in modulating kidney fibrosis in aging mice.
  • To evaluate the impact of MG53 deficiency on kidney fibrosis and inflammation in a mouse model of unilateral ureteral obstruction (UUO).
  • To explore the therapeutic potential of MG53 in mitigating kidney fibrosis and inflammation.

Main Methods:

  • Assessed kidney fibrosis and interstitial fibrosis in aging mice with and without MG53 using histological analysis.
  • Utilized the unilateral ureteral obstruction (UUO) model in MG53-deficient and MG53-intact mice to evaluate fibrosis and inflammation.
  • Conducted in vitro experiments to determine MG53's interaction with NF-κB signaling in proximal tubular epithelial cells.
  • Administered enhanced MG53 expression or recombinant protein to UUO mice to assess therapeutic effects.

Main Results:

  • Mice lacking MG53 exhibited increased interstitial fibrosis with age compared to controls.
  • MG53 deficiency exacerbated kidney fibrosis and inflammation in the UUO model.
  • In vitro studies showed MG53 enters proximal tubular cell nuclei and interacts with p65 subunit of NF-κB.
  • Enhanced MG53 levels reduced NF-κB activation, inflammation, and attenuated kidney fibrosis in UUO mice.

Conclusions:

  • MG53 plays a protective role against kidney fibrosis and inflammation.
  • MG53 deficiency leads to heightened inflammation and fibrosis, potentially through interaction with NF-κB signaling.
  • Augmenting MG53 levels presents a potential therapeutic strategy for chronic kidney inflammation and fibrosis, offering protection against chronic kidney disease progression.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.9K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.2K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
8.0K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
36.5K